CMS Adds New COVID-19 Clinical Trials Improvement Activity to the Quality Payment Program

CMS Adds New COVID-19 Clinical Trials Improvement Activity to the Quality Payment Program CMS issued a letter thanking clinicians for their ongoing efforts to treat patients and combat COVID-19 and shared additional details on the new Merit-Based Incentive Payment System (MIPS) improvement activity. As announced earlier this month, clinicians who participate in a COVID-19 clinical trial and report their findings to a clinical data repository or registry many now earn credit in MIPS under the Improvement Activities performance category for the 2020 performance period by attesting to this new activity. Letter  This and earlier CMS actions in response to the COVID-19 virus, are all part of ongoing White House Coronavirus Task Force efforts. To keep up with the important work the Task Force is doing in response to COVID-19, click here www.coronavirus.gov. For a complete and updated list of CMS actions, guidance, and other information in response to the COVID-19 virus, please visit the, please visit the Current Emergencies Website.